ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial
The Lancet Neurology
◽
10.1016/s1474-4422(15)00144-1
◽
2015
◽
Vol 14
(8)
◽
pp. 795-803
◽
Cited By ~ 125
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Randomised Trial
◽
Phase 2
◽
Double Blind
◽
Early Parkinson’S Disease
Download Full-text
Related Documents
Cited By
References
Faculty Opinions recommendation of Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.725596090.793507964
◽
2015
◽
Author(s):
Joseph Jankovic
◽
Mary Ann Thenganatt
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Randomised Trial
◽
Phase 2
◽
Double Blind
◽
Early Parkinson’S Disease
Download Full-text
Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial
The Lancet Neurology
◽
10.1016/s1474-4422(11)70012-6
◽
2011
◽
Vol 10
(3)
◽
pp. 221-229
◽
Cited By ~ 133
Author(s):
Robert A Hauser
◽
Marc Cantillon
◽
Emmanuelle Pourcher
◽
Federico Micheli
◽
Vincent Mok
◽
...
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Randomised Trial
◽
Motor Fluctuations
◽
Phase 2
◽
Double Blind
Download Full-text
Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial
Yearbook of Neurology and Neurosurgery
◽
10.1016/j.yneu.2011.05.051
◽
2011
◽
Vol 2011
◽
pp. 80-82
Author(s):
S. Papapetropoulos
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Randomised Trial
◽
Motor Fluctuations
◽
Phase 2
◽
Double Blind
Download Full-text
P1-067: AMBROXOL AS PHARMACOLOGICAL CHAPERONE TARGETING GBA1 AS A DISEASE MODIFYING TREATMENT FOR PARKINSON'S DISEASE DEMENTIA: A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Alzheimer s & Dementia
◽
10.1016/j.jalz.2018.06.069
◽
2006
◽
Vol 14
(7S_Part_5)
◽
pp. P296-P296
Author(s):
Stephen H. Pasternak
◽
Carolina Silveira
◽
Zhonghan Li
◽
Robert Bartha
◽
Michael Borrie
◽
...
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Controlled Trial
◽
Phase 2
◽
Parkinson’S Disease Dementia
◽
Double Blind
◽
Pharmacological Chaperone
◽
Double Blind Placebo
◽
Disease Modifying
◽
Disease Modifying Treatment
Download Full-text
Corrigendum to “Rotigotine transdermal patch in Chinese patients with early Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study” [Park. Relat. Disord. 28 (2016) 49–55]
Parkinsonism & Related Disorders
◽
10.1016/j.parkreldis.2017.02.030
◽
2017
◽
Vol 38
◽
pp. 108
Author(s):
Zhen-Xin Zhang
◽
Hui-Fang Shang
◽
Xingyue Hu
◽
Shengdi Chen
◽
Zhongxin Zhao
◽
...
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Chinese Patients
◽
Transdermal Patch
◽
Double Blind
◽
Double Blind Placebo
◽
Pivotal Study
◽
Rotigotine Transdermal Patch
◽
Early Parkinson’S Disease
Download Full-text
A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients
Movement Disorders
◽
10.1002/mds.23954
◽
2011
◽
Vol 27
(1)
◽
pp. 106-112
◽
Cited By ~ 66
Author(s):
Fabrizio Stocchi
◽
Rupam Borgohain
◽
Marco Onofrj
◽
Anthony H.V. Schapira
◽
Mohit Bhatt
◽
...
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Controlled Trial
◽
Double Blind
◽
Double Blind Placebo
◽
Early Parkinson’S Disease
Download Full-text
Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease
Movement Disorders
◽
10.1002/mds.23317
◽
2010
◽
Vol 25
(15)
◽
pp. 2542-2549
◽
Cited By ~ 57
Author(s):
Robert A. Hauser
◽
Anthony H.V. Schapira
◽
Olivier Rascol
◽
Paolo Barone
◽
Yoshikuni Mizuno
◽
...
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Extended Release
◽
Double Blind
◽
Once Daily
◽
Early Parkinson’S Disease
Download Full-text
Faculty Opinions recommendation of AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.9228956.10806055
◽
2011
◽
Author(s):
Bastiaan Bloem
◽
Marjolein Aerts
Keyword(s):
Parkinson’S Disease
◽
Gene Therapy
◽
Parkinson's Disease
◽
Randomised Trial
◽
Double Blind
◽
Advanced Parkinson’S Disease
◽
Sham Surgery
Download Full-text
Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson’s disease: the LEAP-study
BMC Neurology
◽
10.1186/s12883-015-0491-1
◽
2015
◽
Vol 15
(1)
◽
Cited By ~ 7
Author(s):
Constant V. M. Verschuur
◽
S. R. Suwijn
◽
B. Post
◽
M. Dijkgraaf
◽
B. R. Bloem
◽
...
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Double Blind
◽
Double Blind Placebo
◽
Early Parkinson’S Disease
Download Full-text
Mesulergine in early Parkinson's disease: a double blind controlled trial.
Journal of Neurology Neurosurgery & Psychiatry
◽
10.1136/jnnp.49.4.390
◽
1986
◽
Vol 49
(4)
◽
pp. 390-395
◽
Cited By ~ 5
Author(s):
E Dupont
◽
B Mikkelsen
◽
J Jakobsen
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Controlled Trial
◽
Double Blind
◽
Early Parkinson’S Disease
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close